On October 6, 2025, Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) announced that it is preparing to add a third recombinant spider‑silk production facility. CEO Kim Thompson stated that the company is actively identifying a site in one of the world’s leading silk‑producing regions and expects to lock in the location within the next 60 days.
The new facility will expand Kraig Labs’ production capacity and reinforce its multi‑facility strategy, which is designed to support continuous production and build redundancy into the supply chain. By situating the third center in an established sericulture area, the company can leverage experienced local labor, robust infrastructure, and a long‑standing tradition of silk production.
The announcement signals a significant step toward meeting the growing market demand for recombinant spider silk and positions Kraig Labs to accelerate commercial deliveries to its major global brand partners in the second half of 2025. The company’s focus on expanding capacity is expected to enhance its ability to scale production, reduce per‑unit costs, and strengthen its competitive position in the high‑performance fiber market.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.